NCT01451788View on ClinicalTrials.gov

Effect of Human Thrombin With Gelatin Matrix on Perioperative Blood Loss in Scoliosis Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2016

Conditions
Adolescent Idiopathic Scoliosis
Interventions
DEVICE

Gelatin matrix with human derived thrombin (Floseal, Baxter)

Floseal will be used to stop cancellous bone bleeding, pedicle channel bleeding or epidural space bleeding by injecting suitable amount of this matrix and irrigating it away after few minutes.

Trial Locations (3)

Unknown

Helsinki University Central Hospital, Helsinki

Tampere University Central Hospital, Tampere

FI-20521

Turku Children's Hospital, Turku

All Listed Sponsors
collaborator

Tampere University Hospital

OTHER

collaborator

Helsinki University Central Hospital

OTHER

lead

Turku University Hospital

OTHER_GOV

NCT01451788 - Effect of Human Thrombin With Gelatin Matrix on Perioperative Blood Loss in Scoliosis Surgery | Biotech Hunter | Biotech Hunter